Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholder's Equity (Unaudited)

v3.22.4
Condensed Consolidated Statements of Changes in Stockholder's Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Mar. 31, 2021 $ 2 $ 189,217 $ (179,277) $ (4,579) $ 5,363
Beginning balance, shares at Mar. 31, 2021 2,092,909        
Transaction costs related to ATM agreement offering (10) (10)
Employee stock-based compensation expense 56 56
Stock based compensation related to issuance of restricted common stock 3 3
Foreign currency translation adjustment 307 307
Net loss (1,098) (1,098)
Ending balance, value at Jun. 30, 2021 $ 2 189,266 (180,375) (4,272) 4,621
Ending balance, shares at Jun. 30, 2021 2,092,909        
Issuance of common stock in connection with ATM, net of transaction costs $ 1 6,901 6,902
Issuance of common stock in connection with ATM, net of transaction costs, shares 855,500        
Issuance of common stock due to options exercises 193 193
Issuance of common stock due to options exercises, shares 44,042        
Issuance of common stock due to warrants exercises 23 23
Issuance of common stock due to warrants exercises, shares 12,290        
Employee stock-based compensation expense 52 52
Stock based compensation related to issuance of restricted common stock 3 3
Foreign currency translation adjustment (234) (234)
Net loss (100) (100)
Ending balance, value at Sep. 30, 2021 $ 3 196,438 (180,475) (4,506) 11,460
Ending balance, shares at Sep. 30, 2021 3,004,741        
Shares issued in connection with ATM, net of transaction costs 662 662
Shares issued in connection with ATM, net of transaction costs , shares 94,600        
Employee stock-based compensation expense 56 56
Foreign currency translation adjustment (65) (65)
Net loss (944) (944)
Ending balance, value at Dec. 31, 2021 $ 3 197,156 (181,419) (4,571) 11,169
Ending balance, shares at Dec. 31, 2021 3,099,341        
Beginning balance, value at Mar. 31, 2022 $ 2 197,370 (184,363) (4,312) 8,697
Beginning balance, shares at Mar. 31, 2022 3,100,937        
Employee stock-based compensation expense 214 214
Foreign currency translation adjustment (65) (65)
Net loss (887) (887)
Ending balance, value at Jun. 30, 2022 $ 2 197,584 (185,250) (4,377) 7,959
Ending balance, shares at Jun. 30, 2022 3,100,937        
Beginning balance, value at Mar. 31, 2022 $ 2 197,370 (184,363) (4,312) 8,697
Beginning balance, shares at Mar. 31, 2022 3,100,937        
Ending balance, value at Dec. 31, 2022 $ 2 197,939 (188,206) (4,176) 5,559
Ending balance, shares at Dec. 31, 2022 3,109,652        
Beginning balance, value at Jun. 30, 2022 $ 2 197,584 (185,250) (4,377) 7,959
Beginning balance, shares at Jun. 30, 2022 3,100,937        
Employee stock-based compensation expense 108 108
Stock based compensation related to issuance of restricted common stock 5 5
Stock based compensation related to issuance of restricted common stock, shares 2,035        
Foreign currency translation adjustment (34) (34)
Net loss (1,017) (1,017)
Ending balance, value at Sep. 30, 2022 $ 2 197,697 (186,267) (4,411) 7,021
Ending balance, shares at Sep. 30, 2022 3,102,972        
Employee stock-based compensation expense 233 233
Stock based compensation related to issuance of restricted common stock 9 9
Stock based compensation related to issuance of restricted common stock, shares 6,680        
Foreign currency translation adjustment 235 235
Net loss (1,939) (1,939)
Ending balance, value at Dec. 31, 2022 $ 2 $ 197,939 $ (188,206) $ (4,176) $ 5,559
Ending balance, shares at Dec. 31, 2022 3,109,652